Rossari Biotech
Specialty Chemicals · ROSSARI
Small CapBasic MaterialsMature Stable
Sunil Chari
Managing Director · Pragmatic
Company DNA
Founder-Centric
About
Rossari Biotech is a Small Cap company in the Basic Materials sector, listed on NSE as ROSSARI. With a market cap of ₹3K Cr and revenue of ₹2K Cr, it is currently in the Mature Stable phase. Known for its Founder-Centric culture and Fast-Follower approach to innovation, the company operates at a Steady-Marathon pace. Strong promoter holding (68.2%) with active founders managing operations indicates a decision-making process deeply aligned with the founding vision. Its strategic mandate: To evolve beyond its current product base, the firm requires a leader focused on integrating digital technologies into manufacturing to drive margin expansion.
FAQ
What kind of company is Rossari Biotech?
Rossari Biotech is a Small Cap Basic Materials company (ROSSARI) in the Mature Stable phase with a market cap of ₹3K Cr. It is classified as Founder-Centric in culture.
What is Rossari Biotech's culture and work environment like?
Rossari Biotech has a Founder-Centric culture with Fast-Follower innovation DNA and a Steady-Marathon pace of execution. Employee brand: Steady Employer. Customer relationship style: B2B-Enterprise. Strong promoter holding (68.2%) with active founders managing operations indicates a decision-making process deeply aligned with the founding vision.
Who leads Rossari Biotech?
Rossari Biotech is led by Sunil Chari (Managing Director), a Pragmatic leader with 28 years of experience.
What are Rossari Biotech's financials?
Rossari Biotech reported revenue of ₹2K Cr in FY25 with a 5-year revenue CAGR of 12%. Operating margin: 9%. Market cap: ₹3K Cr.
Culture & Strategy
CultureFounder-Centric
InnovationFast-Follower
PaceSteady-Marathon
PurposePurpose-Blended
CustomerB2B-Enterprise
EmployeeSteady Employer
BrandTechnical-Expert
LifecycleMature Stable
Strong promoter holding (68.2%) with active founders managing operations indicates a decision-making process deeply aligned with the founding vision.
Mandate
To evolve beyond its current product base, the firm requires a leader focused on integrating digital technologies into manufacturing to drive margin expansion.
To evolve beyond its current product base, the firm requires a leader focused on integrating digital technologies into manufacturing to drive margin expansion.
Financials
Revenue FY25₹2K Cr
PAT FY25₹136 Cr
Rev CAGR 5Y12%
OPM9%
NPM6.6%
ROE11.5%
ROCE13.8%
P/E18
Fwd P/E15.5
P/B2
D/E28.2
Mkt Cap₹3K Cr
Promoter68.2%
Institutional18.7%
Similar Culture
Could You Lead Rossari Biotech?
Take the Genome Benchmark →